According to Smith & Nephew 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.64388. At the end of 2014 the company had a P/S ratio of 3.58.
Year | P/S ratio | Change |
---|---|---|
2014 | 3.58 | 22.91% |
2013 | 2.91 | 21.39% |
2012 | 2.40 | 19.06% |
2011 | 2.02 | -14.64% |
2010 | 2.36 | -1.95% |
2009 | 2.41 | 60.42% |
2008 | 1.50 | -50.84% |
2007 | 3.05 | -14.06% |
2006 | 3.55 | -40.44% |
2005 | 5.97 | 46.22% |
2004 | 4.08 | 9.75% |
2003 | 3.72 | -45.63% |
2002 | 6.84 | -9.85% |
2001 | 7.58 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 5.09 | 92.58% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | 5.67 | 114.34% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | 9.44 | 257.05% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | 5.89 | 122.92% | ๐บ๐ธ USA |
![]() Orthofix Medical
OFIX | 1.33 | -49.71% | ๐บ๐ธ USA |
![]() CONMED CNMD | 3.03 | 14.49% | ๐บ๐ธ USA |